Skip to main content
Medical information Clinical review pending

Diagnostic Testing

Immunophenotyping By Flow Cytometry Glycophorin Test

The Immunophenotyping By Flow Cytometry Glycophorin Test helps diagnose and monitor blood cancers by analyzing cell surface markers. It provides rapid results to guide treatment decisions.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
3 mL (2 mL min.) whole blood in a Lavender Top (EDTA) tube and a Green Top (Sodium Heparin) tube, OR 2 mL (1 mL min.) bone marrow in a Green Top (Sodium Heparin) tube.
Results
Same-day results if the sample is received by 9 AM. Confirm with the laboratory before booking.
Preparation
No specific patient preparation is required for this blood test. Inform your doctor about any medications you are taking.
Test priceKSh 7,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Immunophenotyping By Flow Cytometry Glycophorin Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Suspected leukemia or lymphoma
  • ✓Monitoring known hematological malignancies
  • ✓Evaluation of abnormal blood counts
  • ✓Diagnosis of blood disorders
  • ✓Assessing response to treatment
  • ✓Characterizing cell populations in blood or bone marrow
02

In plain language

What this test helps you understand

This test is used to identify and characterize blood cell types, aiding in the diagnosis, classification, and monitoring of hematological malignancies like leukemia and lymphoma. It helps distinguish between normal and abnormal cell populations based on surface marker expression.
The Immunophenotyping By Flow Cytometry Glycophorin Test is a specialized diagnostic tool used primarily in the field of oncology and hematology. This test plays a vital role in identifying and characterizing different types of blood cells, particularly in the diagnosis and monitoring of hematological malignancies such as leukemia and lymphoma. By analyzing the surface markers on blood cells, healthcare providers can gain insights into the nature of a patient's disease, enabling personalized treatment approaches.

This test measures the expression of specific antigens on the surface of blood cells, particularly focusing on glycoproteins like glycophorin. These markers are critical in distinguishing between normal and abnormal cell populations, aiding in the identification of malignant cells.

Patients who exhibit symptoms associated with blood cancers, such as unexplained weight loss, fatigue, frequent infections, or abnormal blood counts, should consider this test. Additionally, individuals with risk factors such as a family history of hematological disorders or previous cancer diagnoses may benefit from this diagnostic tool.

Benefits of Taking the Test: - Rapid and accurate diagnosis of blood-related disorders. - Facilitates tailored treatment plans based on specific cell characteristics. - Helps monitor treatment efficacy and disease progression. - Provides crucial information for oncologists and hematologists.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo specific patient preparation is required for this blood test. Inform your doctor about any medications you are taking.
Sample3 mL (2 mL min.) whole blood in a Lavender Top (EDTA) tube and a Green Top (Sodium Heparin) tube, OR 2 mL (1 mL min.) bone marrow in a Green Top (Sodium Heparin) tube.
MethodologyFlow Cytometry
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
Test results must be interpreted by a qualified healthcare professional in conjunction with clinical findings and other laboratory tests. The test may not detect all types of blood disorders.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

Immunophenotyping is a laboratory technique that identifies and characterizes cells based on the specific proteins (antigens) on their surface or inside them, often using antibodies.
Glycophorin is a type of protein found on the surface of red blood cells. Analyzing its expression, along with other markers, helps identify and classify different types of blood cells, including cancerous ones.
A blood sample or a bone marrow sample is collected. Your doctor will advise on the appropriate sample type.
Results are typically available the same day if the sample reaches the lab by 9 AM. Confirm the exact turnaround time with the laboratory.
Blood collection involves a small needle prick, which may cause brief discomfort. Bone marrow aspiration can be more uncomfortable; discuss this with your doctor.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp